Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 10 recruiting now early-phase tilt small index

Autonomic Failure: early-phase trial registry

10 of 12 indexed Autonomic Failure trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 10 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Autonomic Failure: 12 US clinical trials tracked, 10 recruiting.

Autonomic Failure is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Vanderbilt University Medical Center, running 9 of these trials.

Enrollment posture brief

Registry condition autonomic-failure

OPEN 10 | RECR 83% | LATE 0 | EARLY 5 | RANK #1429 | SPON 9

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

Autonomic Failure (this)83%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Autonomic Failure

Autonomic Failure lists 10 open slots (83% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Autonomic Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Autonomic Failure is recruiting above its size-band peers.

    10 of 12 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Autonomic Failure research.

    Vanderbilt University Medical Center accounts for 9 of 12 trials (75%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Autonomic Failure trials plan to enrol fewer than 100 people.

    Median target enrolment is 31 among the 12 trials that report a genuine target (sentinel values excluded). 12 of those (100%) plan for fewer than 100 participants.

  4. Autonomic Failure research is mostly interventional.

    11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 59 participants

CPAP for the Treatment of Supine Hypertension

Vanderbilt University Medical Center

NCT05489575

RECRUITING NA 44 participants

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure

Vanderbilt University Medical Center

NCT04502225

RECRUITING Phase 1 40 participants

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Daniel Claassen

NCT04246437

RECRUITING Phase 1 34 participants

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Vanderbilt University Medical Center

NCT02897063

RECRUITING Early Phase 1 31 participants

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Vanderbilt University Medical Center

NCT04620382

RECRUITING Phase 1 31 participants

Automated Abdominal Binder for Orthostatic Hypotension

Vanderbilt University Medical Center

NCT03482297

RECRUITING NA 29 participants

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Vanderbilt University Medical Center

NCT04782830

RECRUITING Phase 1 29 participants

Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

Vanderbilt University Medical Center

NCT02429557

RECRUITING NA 20 participants

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Vanderbilt University Medical Center

NCT03042988

RECRUITING NA 12 participants

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Vanderbilt University Medical Center

NCT03312556

ACTIVE NOT RECRUITING 89 participants

Clinical Laboratory Evaluation of Chronic Autonomic Failure

National Institute of Neurological Disorders and Stroke (NINDS)

NCT03648905

COMPLETED NA 13 participants

Abdominal Compression in Orthostatic Hypotension

Mayo Clinic

NCT01223391

Phase Distribution

PhaseTrial count
Phase 1 5

Named interventions

Most-linked intervention names on Autonomic Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Midodrine Drug
3 trials
Placebo Drug
3 trials
Placebo pill Drug
2 trials
No abdominal binder Other
1 trials
Abdominal binder Other
1 trials
18F-Dopamine Drug
1 trials
11C-Methylreboxetine (11C-MRB) Drug
1 trials
18F-DOPA Drug
1 trials

US sites by state

Facility locations filed on Autonomic Failure trials. A trial with sites in several states counts in each.

Tennessee 10 trials
Minnesota 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Autonomic Failure page

12 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autonomic Failure condition card totals 12 registered trials; most-linked intervention Midodrine; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.